| 【Company Research】Yancoal Australia (3668 HK) – 1H23E preview: Expect profit decline on weak coal price |
| 【Company Research】PA Good Doctor (1833 HK) – 1H23E preview: Expecting Strategy 2.0 to gain momentum in post-pandemic periods |
| 【Company Research】Sunny Optical (2382 HK) – 1H23 preview: Better ASP to offset shipment weakness; Focus on demand recovery in 2H23E |
| 【Company Research】Intron Technology (1760 HK) – NDR takeaways: Strong order backlog in 2H23E; Solid pipeline to drive growth into FY24/25E |
| 【Company Research】Akeso, Inc. (9926 HK) – A leading biopharma in bi-specific antibodies and other innovative biological therapies |
| 【行业研究】中国传媒与文娱行业 – 视频行业2Q23回顾及展望: 暑期精品内容释放可期 |
| 【Company Research】Chow Tai Fook (1929 HK) – Another solid quarter |
| 【Company Research】NH Health (6606 HK) – Pioneer in China’s cancer screening market |
| 【Economic Perspectives】China Economy – Deflation entrenched as demand remained weak |
| 【Company Research】Alibaba (BABA US) – Fundamentals on constant recovery track |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
